AMIC says initial results on Mo-99 technology promising

11/4/2009 | (free registration)

Radiopharmaceutical developer Advanced Medical Isotope said preliminary tests on its proton linear accelerator-based technology showed positive outcomes. The technology could be used as an alternative to the use of nuclear reactors in the production of the medical isotope molybdenum-99. The company is preparing to start the second round of prototype tests.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI